Months before an Angier company shipped deadly bacteria-tainted drugs, the federal Food and Drug Administration received numerous complaints about sediment and debris in the medicine.
The FDA received reports about AM2PAT as early as 2005, but not until December 2007 did the agency issue recall notices to pull the drugs off the market.
Two men pleaded guilty in U.S. District Court this week for their roles in the scheme, which involved falsifying documents to make it appear that proper sterility tests had been conducted. The company’s president, Dushyant Patel, faces 10 charges, but he has not been arrested.
Health Glance
The FDA today issued a public health advisory about reports of a rare brain infection in people using the psoriasis drug Raptiva.
Mesothelioma has long been linked to the inhalation and exposure to asbestos fibers and dust, so when scientists uncovered an additional potential cause for this incurable form of lung cancer, the unthinkable became a reality.





























